Researchers are yet to conduct long-term trials with ipamorelin
The bottom-up LC-MS/MS approach may or may not be subject to similar bias depending on the selected trypsin-digested peptides for IGF-1 quantitation
Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Standard / Gradual Approach (3 mL reconstitution) Concentration after reconstitution: 2.0 mg/mL AOD-9604 | 1.0 mg/mL CJC-1295 | 1.0 mg/mL Ipamorelin Frequency: Inject once daily subcutaneously, preferably in the morning or before bed on an empty stomach
Mol Cell Endocrinol 93 : 193198 Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, Rubin R (1994) Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors
The dosage charts in this guide are derived from Phase 2 and Phase 3 clinical trial protocols, not from approved prescribing information